390 results on '"Gheorghe, Liana"'
Search Results
52. A real-world study of treating advanced liver cirrhosis due to chronic HCV infection genotype 1b with sofosbuvir+ ledipasvir with or without ribavirin: results from a cohort of 349 patients
53. Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania
54. Domino liver transplantation using a graft from a donor with familial hypercholesterolemia: seven-yr follow-up
55. Drug-induced Sweetʼs syndrome secondary to hepatitis C antiviral therapy
56. Which histopathological and clinical variables are best for predicting the evolution of non-metastased colon cancer
57. Multidisciplinary team approach to hepatocellular carcinoma management: Three year-study in a liver transplant center from Romania
58. Malnutrition Prevalence in Newly Diagnosed Patients with Inflammatory Bowel Disease – Data from the National Romanian Database
59. Tu1545 – Shear Wave Elastography Use for Screening of Clinically Significant Portal Hypertension After Hcv Cure
60. SAT-052-Right psoas muscle area: Prognostic factor in patients with cirrhosis Child Pugh class C included on the waiting list for liver transplantation
61. Diagnosis and Treatment of Colonic Diverticular Disease: Position Paper of the Romanian Society of Gastroenterology and Hepatology
62. Predictive Factors of Tumor Recurrence and Survival in Patients with Hepatocellular Carcinoma treated with Transarterial Chemoembolization
63. 100% Sustained Virological Response and Fibrosis Improvement in Real-Life Use of Direct Acting Antivirals in Genotype-1b Recurrent Hepatitis C following Liver Transplantation
64. Early detection of advanced pancreatic cancer after DAA-induced virological cure in a liver transplant recipient with hepatitis C recurrence
65. The Role of Beta-7 Integrin and Carbonic Anhydrase IX in Predicting the Occurrence of de Novo Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
66. Metabolic Syndromeand Cardiovascular Risk in Liver Transplant Recipients - Can Non-invasive Testing Change the Landscape?
67. New Epidemiologic Data Regarding Hepatitis C Virus Infection in Romania
68. Real‐world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis
69. Position Paper on Treatment of Hepatitis C in Romania 2017. Part Two
70. Real-Life Use of 3 Direct-Acting Antiviral Regimen in a Large Cohort of Patients with Genotype-1b HCV Compensated Cirrhosis
71. Metabolic Syndrome and Genotype 1 Virus C Compensated Liver Cirrhosis in the Era of Directly Acting Antiviral Therapy
72. Dynamics of Liver Stiffness Values by means of Transient Elastography in Patients with HCV Liver Cirrhosis undergoing Interferon Free Treatment
73. Position Paper on Treatment of Hepatitis C in Romania, 2017. Part One
74. Alpha Fetoprotein and a Useful Tool for Surveillance of Interferon-Free Treated Cirrhotic Patients for Hepatocellular Carcinoma After SVR
75. Efficacy and Safety of Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir Plus/Minus Ribavirin for Treatment of HCV Genotype 1B Compensated Cirrhosis in Patients Aged 70 Years or Older
76. Assessing mucosal healing in IBD in daily practice
77. Liver Resections in a High-Volume Center: Form Standard Procedures to Extreme Surgery and Ultrasound-guided Resections
78. Curative Intent Treatment of Hepatocellular Carcinoma - 844 Cases Treated in a General Surgery and Liver Transplantation Center
79. In How Many Patients We Will Misdiagnose Esofageal Varices by Using the Baveno Vi Criteria?
80. The Romanian National Program for Liver Transplantation - 852 Procedures in 815 Patients over 17 Years (2000-2017): A Continuous Evolution to Success
81. What Happened with Liver Stiffness Values Assessed by Means of Transient Elastography in Patients with HCV Liver Cirrhosis after DAA Treatment
82. 100% Virological Response with 3D Regimen and Significant Short-term Liver Stiffness Improvement in Patients with Recurrent Hepatitis C Following Liver Transplantation
83. 100% Virological Response and Adherence in HCV Genotype 1 Liver Cirrhosis Treated with 3D Regimen in a Romanian Real-life Cohort
84. Dynamics of AFP in Cirrhotic Patients with Virological Response Following 3D Therapy and Severe Necro-inflammation at Fibromax
85. A real life boceprevir use in treatment-experienced HCV genotype 1 patients with advanced fibrosis
86. Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists
87. Tuberculin skin test and Quantiferon TB Gold in Romanian BCG vaccinated, immunosuppressed patients with moderate-to-severe Crohn’s disease: a comparison with a Hungarian cohort
88. Sa1644 Acute Kidney Injury Severity Predicts Mortality and Response to Terlipressin in Patients With End Stage Liver Disease Awaiting Liver Transplantation
89. Sa1367 Hepatocyte Reprogramming to a Progenitor-Cell Phenotype Is a Potential Mechanism of Hepatocarcinogenesis - The Role of Reprogramming Factors: OCT4, SOX2 and NANOG
90. Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors
91. Real‐world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.
92. Prevalence of Anemia and Iron Deficiency in Romanian Patients with Inflammatory Bowel Disease: a Prospective Multicenter Study
93. Romanian Guidelines on the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency
94. Building a liver transplant program in a resource limited country: a 15-year retrospective analysis of 648 patients operated in the Romanian National Program
95. A new score to predict outcome after liver transplantation
96. Mo1393 - Dynamic of Liver Stiffness Values by Means of Transient Elastography in Patients with HCV Liver Cirrhosis Undergoing Interferon Free Treatment
97. Tu1541 - Efficacy and Safety of Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir Plus/Minus Ribavirin for Treatment of HCV Genotype 1B Compensated Cirrhosis in Patients Aged 70 Years or Older
98. Sa1465 - Alpha Fetoprotein and a Useful Tool for Surveillance of Interferon-Free Treated Cirrhotic Patients for Hepatocellular Carcinoma After SVR
99. Excellence Centers in Inammatory Bowel Disease in Romania: a Measure of the Quality of Care
100. Mo1776 Quantitative Gene Expression of Liver Enriched Transcription Factors Could Be Used to Predict Tumor Recurrence After Curative Treatment of Hepatocellular Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.